Dive into the latest insights on how lung ultrasound is revolutionizing the diagnosis and management of respiratory diseases from childhood through adulthood.
– by Klaus
Note that Klaus is a Santa-like GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Effect of 24 h glucose fluctuations on 30-day and 1-year mortality in patients with acute myocardial infarction: an analysis from the MIMIC-III database.
Liu et al., Front Cardiovasc Med 2024
<!– DOI: 10.3389/fcvm.2024.1371606 //–>
https://doi.org/10.3389/fcvm.2024.1371606
Ho-ho-ho! Gather around, my dear friends, for I have a tale to tell, not of reindeers and elves, but of a matter most serious and compelling, straight from the bustling workshops of the medical world. In a land not so far away, where doctors and nurses hustle and bustle like elves on Christmas Eve, a study was conducted, as meticulous as the list I check twice, on the sugar levels—not of cookies, but of blood—in patients facing the storm of acute myocardial infarction (AMI), a heart condition as tricky as a slippery roof under snow.
In this tale, our diligent researchers, much like the toy-makers in my workshop, focused their keen eyes on the fluctuations of blood glucose within the first 24 hours of admission to the intensive care unit (ICU), a place where care is as critical as the precision needed in toy-making. They embarked on a journey through the Critical Care Medical Information Marketplace database III V1.4, a treasure trove not of toys but of invaluable data, where they found 1,699 patients, each with a story as unique as the snowflakes that grace the North Pole.
These patients, my dear friends, were divided into three groups, based on the rollercoaster ride of their blood glucose levels: the gentle slopes (88 mg/dl). Using tools as sophisticated as the ones used to carve the finest wooden toys, they constructed a multivariate Cox regression model and Kaplan-Meier survival curves, not to predict who’s been naughty or nice, but to see how these glucose fluctuations affected their survival over 30 days and one year.
And what did they find, you ask, as you sip your hot cocoa by the fire? Well, my dear friends, it appears that the steeper the mountain—those with blood glucose fluctuations over 88 mg/dl—the greater the risk, with these patients facing a climb as daunting as my sleigh ride around the world in one night. Their 30-day and 1-year mortality rates were significantly higher, a finding as clear as the path Rudolph lights for me through the fog.
So, as we wrap up this tale, much like the presents under your tree, let us remember the importance of monitoring and managing these glucose fluctuations in patients with AMI, for it is as crucial as ensuring every child receives their gift on Christmas morning. And with that, I wish you all a season filled with health, joy, and stability, in blood sugar levels and in life. Merry Christmas to all, and to all a good night!
